Our clients range from large multinational pharmaceutical companies through specialty pharma, innovative biotechnology companies, medical device and diagnostic businesses and healthcare services groups. Some of our current clients include:

 

Latest news

overlay
23 Oct 2017

TiGenix granted Orphan Drug Designation from the U.S. FDA for Cx601

View news release View all news

Case studies

overlay
Vectura

FTSE 250, industry-leading device & formulation business for inhaled airways disease

View case study View all case studies

Our team

overlay

Our senior team has worked together for many years, delivering high-level strategic healthcare consultancy with seamless execution and unrivalled market intelligence.

View our team Empty